Could COVID-19 vaccines help people with myeloma live longer?
That's fascinating research about mRNA vaccines potentially boosting immune therapy effectiveness for certain cancers. While the study you mentioned focused on skin and lung cancer, it's important to know what this means for myeloma specifically.
Currently, the Show Full Answer
Could COVID-19 vaccines help people with myeloma live longer?
That's fascinating research about mRNA vaccines potentially boosting immune therapy effectiveness for certain cancers. While the study you mentioned focused on skin and lung cancer, it's important to know what this means for myeloma specifically.
Currently, the available research on COVID-19 vaccines and myeloma focuses on protection against severe COVID-19 illness rather than directly fighting myeloma itself. People with myeloma typically have compromised immune systems, making them more vulnerable to serious complications from COVID-19.
What we know about COVID vaccines and myeloma:
Studies show that many people with myeloma benefit from additional COVID-19 vaccine doses. Research found that over half of those with B-cell blood cancers (including myeloma) who didn't produce antibodies after two doses did develop them after a third dose. Those who already had antibodies showed improved responses after additional doses.
Updated mRNA vaccines from Pfizer and Moderna now target the latest COVID variants, providing better protection against hospitalization and death.
Talk to your doctor about:
Whether you're eligible for updated COVID vaccines based on your current treatment and immune function. Your oncology team can help determine the best vaccination schedule for your specific situation and whether additional protective treatments might be appropriate.
The exciting cancer research is worth monitoring, but personalized medical guidance remains essential for myeloma care.
November 12, 2025